Why We Made Our GLP-1s Inside Our Own Pharmacy

Jobby John
PharmD, FACA

Why We Made Our GLP-1s Inside Our Own Pharmacy

The GLP-1 boom changed medicine. It also exposed how fragile most of healthcare's supply chain really is.

When demand for GLP-1 medications surged, branded products went on shortage. Patients got pushed toward whatever pharmacy could fill a script that week. Quality varied. Pricing varied. Accountability vanished into a chain of middlemen.

We built Nimbus to answer that problem differently. Here is how, and why it matters for the people we serve.

How most GLP-1 medications reach patients today

Walk through the typical path. A telehealth platform writes a script. A third-party compounder fills it. A shipping partner delivers it. The platform, the prescriber, the pharmacy, and the courier are four different companies. If something goes wrong, no one owns the problem.

That model is fast to launch. It is also brittle. Quality control depends on the weakest link, and the patient is the one carrying the risk.

What we did instead

Lake Hills Pharmacy is our pharmacy. We own it. It is a 503A compounding facility, NABP-accredited, with sterile compounding capability and an in-house QA program. Every GLP-1 we fill for a Nimbus patient is made there. Every batch is tested for sterility and endotoxins. Every formulation has a record we can pull up by lot number.

The provider, the pharmacy, the platform, and the patient relationship all live under one roof. If there is a question about a dose, a pharmacist who works in our building can answer it. If a formulation needs adjustment, the prescriber and the compounding pharmacist coordinate directly.

That is what vertical integration looks like in practice. Not a slide in a deck. A patient call resolved the same hour.

What this means for the price

When you remove middlemen, the math changes. We can offer a flat-rate price across any dose, with no commitment required, because the supply chain is short and we control every step.

Other platforms cannot tell that story. They are paying a markup at every handoff and passing it on to the patient, with dose-escalation upcharges hidden in the fine print.

Our pricing is the same whether you are starting on a low dose or stepping up. That is not a marketing trick. It is what becomes possible when you make the medication yourself.

What this means for trust

The most important benefit is harder to put a number on. When a Nimbus patient calls with a question, the answer comes from the same team that compounded the medication, prescribed it, and built the program around it. There is no finger-pointing across companies. There is one team and one record.

Y'all deserve that level of accountability from a healthcare provider. We built the company so we could give it.